Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-12-01 Purchase |
2022-01-07 5:07 pm |
CUMBERLAND PHARMACEUTICALS INC | CPIX | Cearnal Martin E Sr VP/Chief Commercial Officer |
2,114 | $4.5273 | $9,571 | 178,473 (Direct) |
View |
2021-11-01 Purchase |
2021-12-03 5:05 pm |
CUMBERLAND PHARMACEUTICALS INC | CPIX | Cearnal Martin E Sr VP/Chief Commercial Officer |
2,485 | $2.7375 | $6,803 | 176,359 (Direct) |
View |
2021-10-01 Purchase |
2021-11-05 5:15 pm |
CUMBERLAND PHARMACEUTICALS INC | CPIX | Cearnal Martin E Sr VP/Chief Commercial Officer |
2,205 | $2.7205 | $5,999 | 173,874 (Direct) |
View |
2021-09-01 Purchase |
2021-10-01 5:07 pm |
CUMBERLAND PHARMACEUTICALS INC | CPIX | Cearnal Martin E Sr VP/Chief Commercial Officer |
2,205 | $2.829 | $6,238 | 171,669 (Direct) |
View |
2021-08-02 Purchase |
2021-09-10 5:03 pm |
CUMBERLAND PHARMACEUTICALS INC | CPIX | Cearnal Martin E Sr VP/Chief Commercial Officer |
2,205 | $2.9781 | $6,567 | 169,464 (Direct) |
View |
2021-06-30 Purchase |
2021-08-13 5:10 pm |
CUMBERLAND PHARMACEUTICALS INC | CPIX | Cearnal Martin E Sr VP/Chief Commercial Officer |
2,310 | $3.2491 | $7,505 | 167,259 (Direct) |
View |
2021-05-18 Purchase |
2021-07-09 5:10 pm |
CUMBERLAND PHARMACEUTICALS INC | CPIX | Cearnal Martin E Sr VP/Chief Commercial Officer |
3,150 | $3.0143 | $9,495 | 164,949 (Direct) |
View |
2021-04-16 Purchase |
2021-06-08 5:22 pm |
CUMBERLAND PHARMACEUTICALS INC | CPIX | Cearnal Martin E Sr VP/Chief Commercial Officer |
12,985 | $2.8113 | $36,505 | 166,799 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-03-17 Other |
2022-04-29 1:11 pm |
2025-03-17 2031-03-17 |
CUMBERLAND PHARMACEUTICALS INC | CPIX | Cearnal Martin E Sr VP/Chief Commercial Officer |
5,000 | $0 | 178,473 (Direct) |
View |
2022-03-17 Other |
2022-04-29 1:11 pm |
N/A N/A |
CUMBERLAND PHARMACEUTICALS INC | CPIX | Cearnal Martin E Sr VP/Chief Commercial Officer |
15,000 | $2.74 | 178,473 (Direct) |
View |
2021-03-17 Tax Withholding |
2021-06-08 5:22 pm |
N/A N/A |
CUMBERLAND PHARMACEUTICALS INC | CPIX | Cearnal Martin E Sr VP/Chief Commercial Officer |
2,945 | $3.22 | 166,799 (Direct) |
View |
2021-03-17 Option Award |
2021-06-08 5:22 pm |
2025-03-17 2031-03-17 |
CUMBERLAND PHARMACEUTICALS INC | CPIX | Cearnal Martin E Sr VP/Chief Commercial Officer |
5,000 | $0 | 166,799 (Direct) |
View |